SUPN

Supernus Pharmaceuticals (SUPN)

Supernus Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SUPN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/24	05:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/05/24	05:05	GlobeNewswire Inc.	Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/05/10	05:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/05/10	05:05	GlobeNewswire Inc.	Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/05/09	05:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/05/09	05:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/05/09	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/05/09	05:05	GlobeNewswire Inc.	Supernus Announces First Quarter 2024 Financial Results	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/05/07	23:00	PR Newswire (US)	M8 Pharmaceuticals, an Acino company, signs an exclusive licensing agreement with Supernus for Qelbree® (Viloxazine XR) in Latin America	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/05/01	21:00	GlobeNewswire Inc.	Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/04/25	05:05	GlobeNewswire Inc.	Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/04/08	21:00	GlobeNewswire Inc.	Supernus Provides Regulatory Update for SPN-830	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/03/07	06:30	GlobeNewswire Inc.	Supernus to Participate in Two Upcoming Investor Conferences	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/03/01	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/03/01	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/02/29	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/02/29	07:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/02/29	06:30	GlobeNewswire Inc.	Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/02/28	07:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/02/28	07:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/02/28	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/02/28	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/02/28	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/02/28	06:14	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/02/28	06:05	GlobeNewswire Inc.	Supernus Announces Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/02/27	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/02/27	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/02/27	07:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/02/27	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SUPN	Supernus Pharmaceuticals Inc
2024/02/27	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SUPN	Supernus Pharmaceuticals Inc